BackConcert Pharmaceuticals Overview

Concert Pharmaceuticals Research & Development

Research & Development expenses for CNCE.

Quarterly R&D Expenses

$24.36M
↑ 11.37% YoY

As of Sep 30, 2022

Annual R&D Expenses (TTM)

$57.21M
↓ 25.76% YoY

Trailing 12 months ending Sep 30, 2022

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin